Atomic Shake
A hazy, citrus-forward hybrid from Ethos Genetics that's better documented than most modern strains but still mostly marketing.
Atomic Shake is a real, traceable Ethos Genetics release — that part isn't hype. What is hype: the precise effect claims ('uplifting creative buzz') and the implication that you can predict what a strain does from its name or its breeder's marketing copy. Like every modern hybrid, the cannabinoid and terpene numbers vary wildly between phenotypes and grows. Treat it as a citrus-leaning hazy hybrid and let the actual lab report on your jar tell you the rest.
Overview
Atomic Shake is a hybrid cannabis cultivar bred and released by Ethos Genetics, a Colorado-based seed company founded by Colin Gordon [1]. It is marketed as a high-yielding, terpinolene-forward hybrid with citrus and haze notes. Ethos has sold it both as a feminized line and, more recently, as part of its F1 hybrid seed program, which the company markets as offering more uniform plants from seed [1][2].
Like nearly all modern strain names, 'Atomic Shake' refers to a specific breeder's release rather than a stable, standardized variety. Clones and seed packs sold under this name from Ethos itself have the strongest claim to authenticity; cuts circulating under the same name from unrelated sellers may or may not be the same plant Anecdote.
Chemistry: cannabinoids and terpenes
Ethos and retail lab reports place Atomic Shake's THC in roughly the 20–26% range, with CBD under 1% — typical for a contemporary THC-dominant hybrid [1][3]. There is no published peer-reviewed chemotyping of this specific cultivar No data.
The terpene profile is most often described as terpinolene-dominant, with secondary myrcene, ocimene, and caryophyllene [1][3]. Terpinolene-dominant chemotypes are a real and distinguishable group in large-scale cannabis terpene surveys, often associated with 'Haze' and 'Jack'-family lineages [4][5]. However, terpene composition varies substantially between phenotypes, harvests, and even storage conditions — so any single number you see on a menu is a snapshot, not a fixed property of the strain [4].
Note: the popular claim that myrcene above 0.5% makes a strain 'indica-like and sedating' is folklore, not science — there is no controlled human data supporting that threshold Disputed.
Reported effects
There are no strain-specific clinical trials on Atomic Shake, and there almost certainly never will be — controlled trials test isolated compounds, not branded cultivars No data. What exists is user-reported data from retail menus and forums, which describe it as energetic, talkative, and citrus-flavored, with some users reporting anxiety at higher doses [3] Anecdote.
The broader evidence base is more honest about what we actually know:
- THC is the primary driver of acute psychoactive effects across cultivars [6].
- The 'indica vs. sativa' label is a poor predictor of effects; chemotype (cannabinoid + terpene content) is somewhat better, but individual response, tolerance, dose, and set/setting dominate [4][7] Strong evidence.
- Terpinolene-rich chemotypes are often described anecdotally as 'uplifting,' but controlled human evidence that inhaled terpenes at cannabis-flower concentrations produce distinct subjective effects is weak Weak / limited.
In plain terms: if you've enjoyed other terpinolene-dominant, high-THC hazes, you'll probably enjoy Atomic Shake. Beyond that, claims get speculative fast.
Lineage
Ethos has described Atomic Shake's parentage as involving Lemon Shake crossed with an Atomicicle / Atomic Apple-line male, both in-house Ethos lines [1]. Lemon Shake itself is a citrus-forward Ethos hybrid; the Atomic side traces back to Apples & Bananas and related material in the Ethos catalog [1][2].
Lineage disclosures from any single breeder are essentially practitioner-tier claims: there is no independent genetic verification, and parent strains in modern cannabis are themselves polyhybrids with murky histories Weak / limited. Treat the family tree as 'directionally informative' (expect citrus, expect haze influence) rather than a precise pedigree.
Cultivation basics
Per Ethos and grower reports, Atomic Shake finishes in roughly 8–9 weeks of flower indoors, stretches moderately, and produces above-average yields with dense, frosty buds [1][3] Anecdote. It's generally rated as moderate difficulty — not a beginner clone-only diva, but it benefits from topping, defoliation, and good airflow to manage its bushy structure.
General cultivation guidance that actually has evidence behind it:
- Late-flower temperature drops and UV exposure can modestly shift terpene and cannabinoid profiles, but effects are smaller than marketing suggests [8] Weak / limited.
- Harvest timing (trichome maturity) and post-harvest drying/curing have a larger impact on the final terpene profile than most 'secret nutrient' tricks [8] Strong evidence.
If you're growing from Ethos F1 seed, expect more uniformity than from older feminized lines, but still some phenotype variation [2].
Marketing vs. reality
What's real about Atomic Shake:
- It's a documented release from a named, contactable breeder — better provenance than most strains on a dispensary menu.
- It is consistently a high-THC, terpinolene-leaning, citrus-smelling hybrid in the cuts that trace back to Ethos.
What's marketing:
- Specific effect promises ('creative,' 'social,' 'focused'). These come from cherry-picked reviews, not controlled research Anecdote.
- The implication that the strain name guarantees a consistent experience across every dispensary jar. Two 'Atomic Shake' eighths from different growers can differ more than two unrelated strains from the same grower [4].
- Any precise effect-from-terpene story (linalool = relaxing, limonene = mood-lifting at flower doses). Plausible mechanisms exist, but human evidence at realistic inhaled doses is thin Weak / limited.
Buy it because you like terpinolene hazes and trust the grower, not because the name sounds exciting.
Sources
- Practitioner Ethos Genetics. Atomic Shake product and strain information. Ethos Genetics official site.
- Reported Jaeger, K. 'Ethos Genetics launches F1 hybrid cannabis seed line.' Industry coverage of Ethos F1 program, 2023.
- Reported Leafly strain database entry for Atomic Shake (user-reported effects and lab data aggregation).
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Peer-reviewed Reimann-Philipp, U., Speck, M., Orser, C., et al. (2020). Cannabis Chemovar Nomenclature Misrepresents Chemical and Genetic Diversity. Cannabis and Cannabinoid Research.
- Peer-reviewed Curran, H. V., Freeman, T. P., Mokrysz, C., et al. (2016). Keep off the grass? Cannabis, cognition and addiction. Nature Reviews Neuroscience, 17(5), 293–306.
- Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Peer-reviewed Danziger, N., & Bernstein, N. (2021). Light matters: Effect of light spectra on cannabinoid profile and plant development of medical cannabis. Industrial Crops and Products, 164, 113351.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.